Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Voen Med Zh ; 331(8): 20-4, 2010 Aug.
Article in Russian | MEDLINE | ID: mdl-21089428

ABSTRACT

Reninangiotensinaldosterone system is a key link in regulation of blood pressure and causes the target organ damage in hypertensive patients. For many years is not lost interest in the pharmacological blockade of RAAS in order to achieve target levels of BP and prevent damage target organs, particularly kidneys. Most recently recommended for clinical application of direct rennin inhibitor--aliskiren, a number of researcher have proven expressed nephroprotective effect. However, at present there is no unequivocal answer to the question whether there are advantages in combined RAAS blockade in hypertensive patients with use of aliskiren and angiotensinconverting enzyme inhibitor or angiotensin receptor blocker.


Subject(s)
Amides/therapeutic use , Angiotensin-Converting Enzyme Inhibitors/therapeutic use , Antihypertensive Agents/therapeutic use , Fumarates/therapeutic use , Hypertension/drug therapy , Kidney Diseases/prevention & control , Renin-Angiotensin System/drug effects , Amides/adverse effects , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Antihypertensive Agents/adverse effects , Blood Pressure/drug effects , Fumarates/adverse effects , Humans , Hypertension/physiopathology , Kidney/physiopathology , Kidney Diseases/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...